Northland Capital Markets Initiates Coverage On Cardlytics With Outperform Rating, Announces Price Target of $14
Northland Capital Markets Initiates Coverage On Cardlytics With Outperform Rating, Announces Price Target of $14
Northland資本市場啓動對cardlytics的研究覆蓋，給予跑贏大盤評級，並公佈14美元的目標價。
Northland Capital Markets analyst Luke Horton initiates coverage on Cardlytics (NASDAQ:CDLX) with a Outperform rating and announces Price Target of $14.
北國資本市場分析師盧克·霍頓以跑贏大盤的評級啓動了對Cardlytics（納斯達克股票代碼：CDLX）的報道，並宣佈目標股價爲14美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。